- Direction
- Deteriorating
- Own history
- —
- Peers
- 58th
- Persistence
- EMERGING
· Pharmaceutical Preparations
RESEARCH SNAPSHOTSUPERNUS PHARMACEUTICALS, INC.'s latest supported as-filed period reports revenue of $226.8M, 32.4% above the comparable as-filed period; gross margin moved 520 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.10% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 2.91% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 18.05% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 49.94% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 88.09% · CORE
Level · gp.fundamentals.operating_margin
Raw value 9.34% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 143.1%; Inventory / revenue moved 2225 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Gross margin moved 520 bp lower; Operating margin moved 3380 bp lower.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 32.4%; Operating margin moved 3380 bp lower; Operating income changed across a sign change.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 18.0%; Operating margin moved 4069 bp higher; Operating income changed across a sign change.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 78.3%; Capex / revenue moved 3 bp higher.
2 evidence-backed componentsInventory changed +143.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
SUPN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001356576-26-000051SEC ↗8-KOct 29, 2026Period Oct 29, 20260001356576-26-000050SEC ↗8-KOct 26, 2026Period Oct 26, 20260001356576-26-000045SEC ↗8-KOct 22, 2026Period Oct 21, 20260001104659-26-117937SEC ↗8-KOct 19, 2026Period Oct 19, 20260001356576-26-000043SEC ↗8-KOct 15, 2026Period Oct 15, 20260001356576-26-000040SEC ↗4Aug 14, 2026Period Aug 12, 20260001539937-26-000012SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 12, 2026Filed Aug 14, 2026 | Khattar Jack A.President, CEO | Option ExerciseDirect | 29,849 | $0 | $0 | Form 4 ↗ |
| Aug 12, 2026Filed Aug 14, 2026 | Khattar Jack A.President, CEO | Tax WithholdingDirect | 12,642 | $47 | $588,738 | Form 4 ↗ |
| Aug 12, 2026Filed Aug 14, 2026 | Khattar Jack A.President, CEO | Option ExerciseDirect | 29,849 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 11.36% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 3.94% · OPTIONAL
Trade receivables changed +50.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed -520 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +32.4% from the comparable as-filed period.
Operating margin changed -3380 basis points from the comparable as-filed period.
Operating margin changed +4069 basis points from the comparable as-filed period.
Current ratio changed +38.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001836067-26-000010